Pharma & Healthcare
Global Quetiapine Fumarate Sustained Release Tablets Market Research Report 2026
- Mar 17, 26
- ID: 737727
- Pages: 107
- Figures: 106
- Views: 6
This report delivers a comprehensive overview of the global Quetiapine Fumarate Sustained Release Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Quetiapine Fumarate Sustained Release Tablets. The Quetiapine Fumarate Sustained Release Tablets market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Quetiapine Fumarate Sustained Release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Quetiapine Fumarate Sustained Release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Luye Pharma Limited
PHARMATHEN INVESTMENTS GROUP LIMITED
Seroquel
Teva Pharmaceutical Industries
Dr. Reddy's Laboratories
Sun Pharmaceutical Industries
Mylan N.V.
Torrent Pharmaceuticals
Lupin Limited
Sandoz
Segment by Type
50mg
200mg
300mg
400mg
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Quetiapine Fumarate Sustained Release Tablets companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Quetiapine Fumarate Sustained Release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Quetiapine Fumarate Sustained Release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Luye Pharma Limited
PHARMATHEN INVESTMENTS GROUP LIMITED
Seroquel
Teva Pharmaceutical Industries
Dr. Reddy's Laboratories
Sun Pharmaceutical Industries
Mylan N.V.
Torrent Pharmaceuticals
Lupin Limited
Sandoz
Segment by Type
50mg
200mg
300mg
400mg
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Quetiapine Fumarate Sustained Release Tablets companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 50mg
1.2.3 200mg
1.2.4 300mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Sustained Release Tablets Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Perspective (2021–2032)
2.2 Global Quetiapine Fumarate Sustained Release Tablets Growth Trends by Region
2.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Region (2021–2026)
2.2.3 Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Region (2027–2032)
2.3 Quetiapine Fumarate Sustained Release Tablets Market Dynamics
2.3.1 Quetiapine Fumarate Sustained Release Tablets Industry Trends
2.3.2 Quetiapine Fumarate Sustained Release Tablets Market Drivers
2.3.3 Quetiapine Fumarate Sustained Release Tablets Market Challenges
2.3.4 Quetiapine Fumarate Sustained Release Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Quetiapine Fumarate Sustained Release Tablets Players by Revenue
3.1.1 Global Top Quetiapine Fumarate Sustained Release Tablets Players by Revenue (2021–2026)
3.1.2 Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Players (2021–2026)
3.2 Global Top Quetiapine Fumarate Sustained Release Tablets Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Quetiapine Fumarate Sustained Release Tablets Revenue
3.4 Global Quetiapine Fumarate Sustained Release Tablets Market Concentration Ratio
3.4.1 Global Quetiapine Fumarate Sustained Release Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Quetiapine Fumarate Sustained Release Tablets Revenue in 2025
3.5 Global Key Players of Quetiapine Fumarate Sustained Release Tablets Head Offices and Areas Served
3.6 Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Products and Applications
3.7 Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Quetiapine Fumarate Sustained Release Tablets Breakdown Data by Type
4.1 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Type (2021–2026)
4.2 Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Type (2027–2032)
5 Quetiapine Fumarate Sustained Release Tablets Breakdown Data by Application
5.1 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Application (2021–2026)
5.2 Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
6.2 North America Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
6.4 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
7.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
7.4 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
8.2 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021–2026)
8.4 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
9.2 Latin America Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
9.4 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
10.2 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
10.4 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luye Pharma Limited
11.1.1 Luye Pharma Limited Company Details
11.1.2 Luye Pharma Limited Business Overview
11.1.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Introduction
11.1.4 Luye Pharma Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.1.5 Luye Pharma Limited Recent Development
11.2 PHARMATHEN INVESTMENTS GROUP LIMITED
11.2.1 PHARMATHEN INVESTMENTS GROUP LIMITED Company Details
11.2.2 PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
11.2.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Introduction
11.2.4 PHARMATHEN INVESTMENTS GROUP LIMITED Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.2.5 PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development
11.3 Seroquel
11.3.1 Seroquel Company Details
11.3.2 Seroquel Business Overview
11.3.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Introduction
11.3.4 Seroquel Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.3.5 Seroquel Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Teva Pharmaceutical Industries Business Overview
11.4.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Introduction
11.4.4 Teva Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Details
11.5.2 Dr. Reddy's Laboratories Business Overview
11.5.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Introduction
11.5.4 Dr. Reddy's Laboratories Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.5.5 Dr. Reddy's Laboratories Recent Development
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Company Details
11.6.2 Sun Pharmaceutical Industries Business Overview
11.6.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Introduction
11.6.4 Sun Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.6.5 Sun Pharmaceutical Industries Recent Development
11.7 Mylan N.V.
11.7.1 Mylan N.V. Company Details
11.7.2 Mylan N.V. Business Overview
11.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Introduction
11.7.4 Mylan N.V. Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.7.5 Mylan N.V. Recent Development
11.8 Torrent Pharmaceuticals
11.8.1 Torrent Pharmaceuticals Company Details
11.8.2 Torrent Pharmaceuticals Business Overview
11.8.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Introduction
11.8.4 Torrent Pharmaceuticals Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.8.5 Torrent Pharmaceuticals Recent Development
11.9 Lupin Limited
11.9.1 Lupin Limited Company Details
11.9.2 Lupin Limited Business Overview
11.9.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Introduction
11.9.4 Lupin Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.9.5 Lupin Limited Recent Development
11.10 Sandoz
11.10.1 Sandoz Company Details
11.10.2 Sandoz Business Overview
11.10.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Introduction
11.10.4 Sandoz Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.10.5 Sandoz Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 50mg
1.2.3 200mg
1.2.4 300mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Sustained Release Tablets Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Perspective (2021–2032)
2.2 Global Quetiapine Fumarate Sustained Release Tablets Growth Trends by Region
2.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Region (2021–2026)
2.2.3 Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Region (2027–2032)
2.3 Quetiapine Fumarate Sustained Release Tablets Market Dynamics
2.3.1 Quetiapine Fumarate Sustained Release Tablets Industry Trends
2.3.2 Quetiapine Fumarate Sustained Release Tablets Market Drivers
2.3.3 Quetiapine Fumarate Sustained Release Tablets Market Challenges
2.3.4 Quetiapine Fumarate Sustained Release Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Quetiapine Fumarate Sustained Release Tablets Players by Revenue
3.1.1 Global Top Quetiapine Fumarate Sustained Release Tablets Players by Revenue (2021–2026)
3.1.2 Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Players (2021–2026)
3.2 Global Top Quetiapine Fumarate Sustained Release Tablets Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Quetiapine Fumarate Sustained Release Tablets Revenue
3.4 Global Quetiapine Fumarate Sustained Release Tablets Market Concentration Ratio
3.4.1 Global Quetiapine Fumarate Sustained Release Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Quetiapine Fumarate Sustained Release Tablets Revenue in 2025
3.5 Global Key Players of Quetiapine Fumarate Sustained Release Tablets Head Offices and Areas Served
3.6 Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Products and Applications
3.7 Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Quetiapine Fumarate Sustained Release Tablets Breakdown Data by Type
4.1 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Type (2021–2026)
4.2 Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Type (2027–2032)
5 Quetiapine Fumarate Sustained Release Tablets Breakdown Data by Application
5.1 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Application (2021–2026)
5.2 Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
6.2 North America Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
6.4 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
7.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
7.4 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
8.2 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021–2026)
8.4 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
9.2 Latin America Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
9.4 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
10.2 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
10.4 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luye Pharma Limited
11.1.1 Luye Pharma Limited Company Details
11.1.2 Luye Pharma Limited Business Overview
11.1.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Introduction
11.1.4 Luye Pharma Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.1.5 Luye Pharma Limited Recent Development
11.2 PHARMATHEN INVESTMENTS GROUP LIMITED
11.2.1 PHARMATHEN INVESTMENTS GROUP LIMITED Company Details
11.2.2 PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
11.2.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Introduction
11.2.4 PHARMATHEN INVESTMENTS GROUP LIMITED Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.2.5 PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development
11.3 Seroquel
11.3.1 Seroquel Company Details
11.3.2 Seroquel Business Overview
11.3.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Introduction
11.3.4 Seroquel Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.3.5 Seroquel Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Teva Pharmaceutical Industries Business Overview
11.4.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Introduction
11.4.4 Teva Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Details
11.5.2 Dr. Reddy's Laboratories Business Overview
11.5.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Introduction
11.5.4 Dr. Reddy's Laboratories Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.5.5 Dr. Reddy's Laboratories Recent Development
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Company Details
11.6.2 Sun Pharmaceutical Industries Business Overview
11.6.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Introduction
11.6.4 Sun Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.6.5 Sun Pharmaceutical Industries Recent Development
11.7 Mylan N.V.
11.7.1 Mylan N.V. Company Details
11.7.2 Mylan N.V. Business Overview
11.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Introduction
11.7.4 Mylan N.V. Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.7.5 Mylan N.V. Recent Development
11.8 Torrent Pharmaceuticals
11.8.1 Torrent Pharmaceuticals Company Details
11.8.2 Torrent Pharmaceuticals Business Overview
11.8.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Introduction
11.8.4 Torrent Pharmaceuticals Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.8.5 Torrent Pharmaceuticals Recent Development
11.9 Lupin Limited
11.9.1 Lupin Limited Company Details
11.9.2 Lupin Limited Business Overview
11.9.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Introduction
11.9.4 Lupin Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.9.5 Lupin Limited Recent Development
11.10 Sandoz
11.10.1 Sandoz Company Details
11.10.2 Sandoz Business Overview
11.10.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Introduction
11.10.4 Sandoz Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.10.5 Sandoz Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 50mg
Table 3. Key Players of 200mg
Table 4. Key Players of 300mg
Table 5. Key Players of 400mg
Table 6. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2021–2026
Table 9. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2021–2026)
Table 10. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2027–2032)
Table 12. Quetiapine Fumarate Sustained Release Tablets Market Trends
Table 13. Quetiapine Fumarate Sustained Release Tablets Market Drivers
Table 14. Quetiapine Fumarate Sustained Release Tablets Market Challenges
Table 15. Quetiapine Fumarate Sustained Release Tablets Market Restraints
Table 16. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Players (US$ Million), 2021–2026
Table 17. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Players (2021–2026)
Table 18. Global Top Quetiapine Fumarate Sustained Release Tablets Players by Tier (Tier 1, Tier 2, and Tier 3), based on Quetiapine Fumarate Sustained Release Tablets Revenue, 2025
Table 19. Ranking of Global Top Quetiapine Fumarate Sustained Release Tablets Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Quetiapine Fumarate Sustained Release Tablets Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Headquarters and Area Served
Table 22. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Products and Applications
Table 23. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type (US$ Million), 2021–2026
Table 26. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Type (2021–2026)
Table 27. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Type (2027–2032)
Table 29. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (US$ Million), 2021–2026
Table 30. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Application (2021–2026)
Table 31. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Application (2027–2032)
Table 33. North America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
Table 35. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
Table 48. Luye Pharma Limited Company Details
Table 49. Luye Pharma Limited Business Overview
Table 50. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product
Table 51. Luye Pharma Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 52. Luye Pharma Limited Recent Development
Table 53. PHARMATHEN INVESTMENTS GROUP LIMITED Company Details
Table 54. PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
Table 55. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product
Table 56. PHARMATHEN INVESTMENTS GROUP LIMITED Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 57. PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development
Table 58. Seroquel Company Details
Table 59. Seroquel Business Overview
Table 60. Seroquel Quetiapine Fumarate Sustained Release Tablets Product
Table 61. Seroquel Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 62. Seroquel Recent Development
Table 63. Teva Pharmaceutical Industries Company Details
Table 64. Teva Pharmaceutical Industries Business Overview
Table 65. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product
Table 66. Teva Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 67. Teva Pharmaceutical Industries Recent Development
Table 68. Dr. Reddy's Laboratories Company Details
Table 69. Dr. Reddy's Laboratories Business Overview
Table 70. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product
Table 71. Dr. Reddy's Laboratories Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 72. Dr. Reddy's Laboratories Recent Development
Table 73. Sun Pharmaceutical Industries Company Details
Table 74. Sun Pharmaceutical Industries Business Overview
Table 75. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product
Table 76. Sun Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 77. Sun Pharmaceutical Industries Recent Development
Table 78. Mylan N.V. Company Details
Table 79. Mylan N.V. Business Overview
Table 80. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product
Table 81. Mylan N.V. Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 82. Mylan N.V. Recent Development
Table 83. Torrent Pharmaceuticals Company Details
Table 84. Torrent Pharmaceuticals Business Overview
Table 85. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product
Table 86. Torrent Pharmaceuticals Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 87. Torrent Pharmaceuticals Recent Development
Table 88. Lupin Limited Company Details
Table 89. Lupin Limited Business Overview
Table 90. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product
Table 91. Lupin Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 92. Lupin Limited Recent Development
Table 93. Sandoz Company Details
Table 94. Sandoz Business Overview
Table 95. Sandoz Quetiapine Fumarate Sustained Release Tablets Product
Table 96. Sandoz Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 97. Sandoz Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Quetiapine Fumarate Sustained Release Tablets Picture
Figure 2. Global Quetiapine Fumarate Sustained Release Tablets Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Type: 2025 vs 2032
Figure 4. 50mg Features
Figure 5. 200mg Features
Figure 6. 300mg Features
Figure 7. 400mg Features
Figure 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Quetiapine Fumarate Sustained Release Tablets Report Years Considered
Figure 14. Global Quetiapine Fumarate Sustained Release Tablets Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Quetiapine Fumarate Sustained Release Tablets Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region: 2025 vs 2032
Figure 17. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Players in 2025
Figure 18. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Quetiapine Fumarate Sustained Release Tablets Revenue in 2025
Figure 20. North America Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
Figure 22. United States Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
Figure 26. Germany Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2021–2032)
Figure 34. China Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
Figure 42. Mexico Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
Figure 46. Israel Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Luye Pharma Limited Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 50. PHARMATHEN INVESTMENTS GROUP LIMITED Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 51. Seroquel Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 53. Dr. Reddy's Laboratories Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 55. Mylan N.V. Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 56. Torrent Pharmaceuticals Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 57. Lupin Limited Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 58. Sandoz Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of 50mg
Table 3. Key Players of 200mg
Table 4. Key Players of 300mg
Table 5. Key Players of 400mg
Table 6. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2021–2026
Table 9. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2021–2026)
Table 10. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2027–2032)
Table 12. Quetiapine Fumarate Sustained Release Tablets Market Trends
Table 13. Quetiapine Fumarate Sustained Release Tablets Market Drivers
Table 14. Quetiapine Fumarate Sustained Release Tablets Market Challenges
Table 15. Quetiapine Fumarate Sustained Release Tablets Market Restraints
Table 16. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Players (US$ Million), 2021–2026
Table 17. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Players (2021–2026)
Table 18. Global Top Quetiapine Fumarate Sustained Release Tablets Players by Tier (Tier 1, Tier 2, and Tier 3), based on Quetiapine Fumarate Sustained Release Tablets Revenue, 2025
Table 19. Ranking of Global Top Quetiapine Fumarate Sustained Release Tablets Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Quetiapine Fumarate Sustained Release Tablets Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Headquarters and Area Served
Table 22. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Products and Applications
Table 23. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type (US$ Million), 2021–2026
Table 26. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Type (2021–2026)
Table 27. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Type (2027–2032)
Table 29. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (US$ Million), 2021–2026
Table 30. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Application (2021–2026)
Table 31. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Application (2027–2032)
Table 33. North America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
Table 35. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
Table 48. Luye Pharma Limited Company Details
Table 49. Luye Pharma Limited Business Overview
Table 50. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product
Table 51. Luye Pharma Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 52. Luye Pharma Limited Recent Development
Table 53. PHARMATHEN INVESTMENTS GROUP LIMITED Company Details
Table 54. PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
Table 55. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product
Table 56. PHARMATHEN INVESTMENTS GROUP LIMITED Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 57. PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development
Table 58. Seroquel Company Details
Table 59. Seroquel Business Overview
Table 60. Seroquel Quetiapine Fumarate Sustained Release Tablets Product
Table 61. Seroquel Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 62. Seroquel Recent Development
Table 63. Teva Pharmaceutical Industries Company Details
Table 64. Teva Pharmaceutical Industries Business Overview
Table 65. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product
Table 66. Teva Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 67. Teva Pharmaceutical Industries Recent Development
Table 68. Dr. Reddy's Laboratories Company Details
Table 69. Dr. Reddy's Laboratories Business Overview
Table 70. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product
Table 71. Dr. Reddy's Laboratories Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 72. Dr. Reddy's Laboratories Recent Development
Table 73. Sun Pharmaceutical Industries Company Details
Table 74. Sun Pharmaceutical Industries Business Overview
Table 75. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product
Table 76. Sun Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 77. Sun Pharmaceutical Industries Recent Development
Table 78. Mylan N.V. Company Details
Table 79. Mylan N.V. Business Overview
Table 80. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product
Table 81. Mylan N.V. Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 82. Mylan N.V. Recent Development
Table 83. Torrent Pharmaceuticals Company Details
Table 84. Torrent Pharmaceuticals Business Overview
Table 85. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product
Table 86. Torrent Pharmaceuticals Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 87. Torrent Pharmaceuticals Recent Development
Table 88. Lupin Limited Company Details
Table 89. Lupin Limited Business Overview
Table 90. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product
Table 91. Lupin Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 92. Lupin Limited Recent Development
Table 93. Sandoz Company Details
Table 94. Sandoz Business Overview
Table 95. Sandoz Quetiapine Fumarate Sustained Release Tablets Product
Table 96. Sandoz Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
Table 97. Sandoz Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Quetiapine Fumarate Sustained Release Tablets Picture
Figure 2. Global Quetiapine Fumarate Sustained Release Tablets Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Type: 2025 vs 2032
Figure 4. 50mg Features
Figure 5. 200mg Features
Figure 6. 300mg Features
Figure 7. 400mg Features
Figure 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Quetiapine Fumarate Sustained Release Tablets Report Years Considered
Figure 14. Global Quetiapine Fumarate Sustained Release Tablets Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Quetiapine Fumarate Sustained Release Tablets Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region: 2025 vs 2032
Figure 17. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Players in 2025
Figure 18. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Quetiapine Fumarate Sustained Release Tablets Revenue in 2025
Figure 20. North America Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
Figure 22. United States Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
Figure 26. Germany Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2021–2032)
Figure 34. China Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
Figure 42. Mexico Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
Figure 46. Israel Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Luye Pharma Limited Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 50. PHARMATHEN INVESTMENTS GROUP LIMITED Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 51. Seroquel Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 53. Dr. Reddy's Laboratories Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 55. Mylan N.V. Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 56. Torrent Pharmaceuticals Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 57. Lupin Limited Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 58. Sandoz Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232